TP53 and colorectal carcinoma: We focus on GOF mechanisms of mutant p53 in CRC, but also describe GOF effects which have been shown in other types of cancer, but to the best of our knowledge have not been investigated in CRC so far and might also be relevant in CRC (Figure 5).